These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 21570062)

  • 1. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
    Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
    Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
    Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8.
    Lan T; Putta MR; Wang D; Dai M; Yu D; Kandimalla ER; Agrawal S
    Biochem Biophys Res Commun; 2009 Aug; 386(3):443-8. PubMed ID: 19523922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
    Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8.
    Lan T; Bhagat L; Wang D; Dai M; Kandimalla ER; Agrawal S
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2044-7. PubMed ID: 19269175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
    Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
    Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
    Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
    Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
    Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
    Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
    J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
    Hamm S; Rath S; Michel S; Baumgartner R
    J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8.
    Lan T; Kandimalla ER
    Methods Mol Biol; 2011; 764():249-61. PubMed ID: 21748646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses.
    Forsbach A; Nemorin JG; Montino C; Müller C; Samulowitz U; Vicari AP; Jurk M; Mutwiri GK; Krieg AM; Lipford GB; Vollmer J
    J Immunol; 2008 Mar; 180(6):3729-38. PubMed ID: 18322178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8.
    Wang D; Precopio M; Lan T; Yu D; Tang JX; Kandimalla ER; Agrawal S
    Mol Cancer Ther; 2010 Jun; 9(6):1788-97. PubMed ID: 20515950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
    Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
    J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
    Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
    J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
    Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
    Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats.
    Hammerbeck DM; Burleson GR; Schuller CJ; Vasilakos JP; Tomai M; Egging E; Cochran FR; Woulfe S; Miller RL
    Antiviral Res; 2007 Jan; 73(1):1-11. PubMed ID: 16959331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns.
    Cardoso EC; Pereira NZ; Mitsunari GE; Oliveira LM; Ruocco RM; Francisco RP; Zugaib M; da Silva Duarte AJ; Sato MN
    PLoS One; 2013; 8(6):e67036. PubMed ID: 23826189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.